drug
sodium thiosulfate
Marketedupdated 3mo agoby $REGN REGENERON PHARMACEUTICALS, INC.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(1)
Trials studying sodium thiosulfate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 20, 2029
~3.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Jul 1, 2039formulationUS 11291728
- Jul 1, 2039formulationUS 11510984
- Jul 1, 2039formulationUS 11617793
- Jul 1, 2039method-of-use (U-3898)US 11964018
- Jul 1, 2039method-of-use (U-3948)US 11992530
- Jul 1, 2039method-of-use (U-3952)US 11998604
- Mar 29, 2031compositionUS 84969734.6y
- Jul 7, 2030formulationUS 104796863.9y
- Jul 7, 2030compositionUS 93457243.9y
- Jul 7, 2030compositionUS 95859123.9y
- Feb 10, 2030compositionUS 117533013.5y
- Feb 10, 2030formulationUS 123048133.5y
FDA exclusivities (1)
- Sep 20, 2029ODE-384Orphan Drug (7y)3.1y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that